KYMR 8-K 2026-01-13

Kymera Therapeutics, Inc. (KYMR) 8-K dated 2026-01-13 — accession 0001193125-26-011104. This URL is the filing, not the KYMR hub.

Kymera Therapeutics, Inc. (KYMR) is a biotechnology company listed on NASDAQ.

Kymera Therapeutics, Inc. filed a 8-K on 2026-01-13. Accession 0001193125-26-011104.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported KYMR revenue for 2025-12-31 was $39.2M. Net income was -$311.4M. Revenue was down 16.7% from 2024-12-31 to 2025-12-31. KYMR currently screens at market cap $7.39B.

Not investment advice. The KYMR SEC hub lists recent forms. The stock page is the research view.